ResearcherUniversity of the Basque CountryActive in the last 2 years
Luís Bujanda
Matched on ORCID iD 0000-0002-4353-9968; OpenAlex author ID A5084259836. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 3, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 13
- Pancreatic cancer and biliary tract tumors in individuals with lynch syndrome. Co-author DOI 10.1016/j.dld.2025.09.025↗
- Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Co-author DOI 10.3390/cancers16223779↗
- Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing. First author DOI 10.1016/j.gastrohep.2021.12.011↗
- CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort. Last author DOI 10.1007/s11033-020-05245-5↗
- A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers12061433↗
- Pancreatic Cancer in Lynch Syndrome Patients. Co-author DOI 10.7150/jca.20750↗
- Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have. First author DOI 10.21037/atm.2016.03.44↗
- Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. First author DOI 10.3978/j.issn.2305-5839.2015.10.39↗
- Retinoic Acid Reduces Stem Cell-Like Features in Pancreatic Cancer Cells. Last author DOI 10.1097/mpa.0000000000000373↗
- Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. Co-author DOI 10.1038/cddis.2014.102↗
- Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells Co-author DOI 10.1038/cddis.2014.341↗
- Molecular markers in pancreatic cancer diagnosis. Last author DOI 10.1016/j.cca.2012.12.025↗
- SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Co-author DOI 10.1038/oncsis.2013.23↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marta Herreros‐Villanueva · 12 shared papers, 2013–2025 · strength 1.29
- Paper Pancreatic cancer and biliary tract tumors in individuals with lynch syndrome. DOI 10.1016/j.dld.2025.09.025↗
- Paper Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing. DOI 10.1016/j.gastrohep.2021.12.011↗
- Paper Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. DOI 10.3390/cancers16223779↗
- Leticia Moreira · 2 shared papers, 2024–2025 · strength 0.38
- María Consuelo Artigas · 1 shared paper, 2022 · strength 0.17
- Joan Llach · 1 shared paper, 2024 · strength 0.16
- Fabio Ausania · 1 shared paper, 2024 · strength 0.16
- Julie Earl · 1 shared paper, 2024 · strength 0.16
- Alexander Otto König · 3 shared papers, 2013–2014 · strength 0.11
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. DOI 10.1038/cddis.2014.102↗
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells DOI 10.1038/cddis.2014.341↗
- Paper SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. DOI 10.1038/oncsis.2013.23↗
- Daniel D. Billadeau · 3 shared papers, 2013–2014 · strength 0.11
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. DOI 10.1038/cddis.2014.102↗
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells DOI 10.1038/cddis.2014.341↗
- Paper SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. DOI 10.1038/oncsis.2013.23↗
- Enrique de‐Madaria · 1 shared paper, 2020 · strength 0.09
- Rocı́o I.R. Macı́as · 1 shared paper, 2020 · strength 0.09
- Adelaida La Casta · 1 shared paper, 2020 · strength 0.09
- Luis Muñoz‐Bellvís · 1 shared paper, 2020 · strength 0.09
- José J.G. Marı́n · 1 shared paper, 2020 · strength 0.09
- María Laura Gutiérrez · 1 shared paper, 2020 · strength 0.09
- Volker Ellenrieder · 2 shared papers, 2014 · strength 0.08
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. DOI 10.1038/cddis.2014.102↗
- Paper Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells DOI 10.1038/cddis.2014.341↗
- Zhang Js · 2 shared papers, 2013–2014 · strength 0.07
- Meritxell Gironella · 1 shared paper, 2013 · strength 0.05
- J-S Zhang · 1 shared paper, 2014 · strength 0.04
- Zhi-Hui Deng · 1 shared paper, 2014 · strength 0.04
- Thomas C. Smyrk · 1 shared paper, 2013 · strength 0.03
- Diane M. Simeone · 1 shared paper, 2013 · strength 0.03
- Ethan V. Abel · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.